Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain

por Rubio-Terrés, Carlos, Graefenhain de Codes, Ruth, Rubio-Rodríguez, Darío, Evers, Thomas, Grau Cerrato, Santiago
Publicado 2016

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain

por Granero Xiberta, Xavier, Murcia, Antonio, Troncoso Durán, José Ricardo, Gómez Zubeldia, Claudio, Llorac Moix, Aleix, Graefenhain De Codes, Ruth, Ferrario, Maria Giovana, Lizán, Luis
Publicado 2016